Clinical Trial Update: Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.

View source ↗

Summary

The completed clinical trial evaluated the effects of Dimethyl Fumarate on cognitive performance and brain abnormalities in individuals with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo | Conditions: Multiple Sclerosis | Status: COMPLETED